logo

For the Inventor, By the Inventor

Ottawa, Canada

Variation Biotechnologies Inc.

Calculating rank
USPTO Granted Patents = 20

% Expired Patents = 35.0



Forward Citations = 46

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal David E Anderson (17 out of 19 patents)

silverMedal Anne-Catherine Fluckiger (6 out of 6 patents)

bronzeMedal Andrei Ogrel (4 out of 4 patents)

4.  Jasminka Bozic (3 out of 3 patents)

5.  Marc J Kirchmeier (2 out of 2 patents)

6.  Tanvir Ahmed (2 out of 2 patents)

7.  Barthelemy Ontsouka (2 out of 2 patents)

8.  Francisco Diaz-Mitoma (2 out of 2 patents)

9.  José Vidal Torres (2 out of 2 patents)

10.  David Klatzmann (1 out of 34 patents)

11.  Charlotte Dalba-Fribert (1 out of 1 patent)

12.  Maura Ellen Campbell (1 out of 1 patent)

13.  Hoang-Thanh Le (1 out of 4 patents)

14.  Ronald Erwin Boch (1 out of 1 patent)

15.  Jeff Baxter (1 out of 1 patent)


20 patents:

1. 12421283 - Compositions and methods for treatment of cytomegalovirus (2025-09-23),
2. 12128100 - Immunogenic compositions for treatment of Hepatitis B (2024-10-29),
3. 11253587 - Vaccine compositions for the treatment of coronavirus (2022-02-22),
4. 11248026 - Compositions and methods for treatment of cytomegalovirus (2022-02-15),
5. 11167033 - Compositions and methods for treating viral infections (2021-11-09),
6. 11167032 - Methods and compositions for therapeutic agents (2021-11-09),
7. 10736844 - Compositions and methods for treating viral infections (2020-08-11),
8. 10456460 - Vaccine compositions for treatment of Zika virus (2019-10-29),
9. 10161010 - Methods for detection of anti-cytomegalovirus neutralizing antibodies (2018-12-25),
10. 10105440 - Synthetic derivatives of MPL and uses thereof (2018-10-23),
11. 10006096 - Methods for detection of anti-cytomegalovirus neutralizing antibodies (2018-06-26),
12. 9907746 - Methods for preparing vesicles and formulations produced therefrom (2018-03-06),
13. 9849173 - Methods for preparing vesicles and formulations produced therefrom (2017-12-26),
14. 9833505 - Vaccine compositions for treatment of Zika virus (2017-12-05),
15. 9777043 - Compositions and methods for treatment of cytomegalovirus (2017-10-03),
Company Overview
Variation Biotechnologies Inc. is a biotechnology company based in Ottawa, Canada, specializing in the development of innovative vaccine technologies. The organization focuses on creating advanced immunotherapeutics and vaccine candidates, leveraging proprietary platforms to enhance immune responses. With a commitment to addressing global health challenges, Variation Biotechnologies aims to contribute to the fields of infectious diseases and immunology through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#50 in Ottawa

#725 in Canada

#31,295 in the World

Ottawa, CA
Ottawa, Canada

Variation Biotechnologies Inc.

Forward Citations = 46

17 inventors:

goldMedal David E Anderson (17 out of 19 patents)

silverMedal Anne-Catherine Fluckiger (6 out of 6 patents)

bronzeMedal Andrei Ogrel (4 out of 4 patents)

4.  Jasminka Bozic (3 out of 3 patents)

5.  Marc J Kirchmeier (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Variation Biotechnologies Inc.. Retrieved from https://idiyas.com/company/variation-biotechnologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…